4 results match your criteria: "Rechts der Isar Hospital Technical University of Munich[Affiliation]"
Decision Coaching for Healthy Women With BRCA1/2 Pathogenic Variants—Findings of the Randomized Controlled EDCP-BRCA Trial.
Dtsch Arztebl Int
June 2024
Faculty of Medicine, University of Cologne and Institute for Health Economics and Clinical Epidemiology, Cologne; Faculty of Medicine, University of Cologne and Center for Familial Breast and Ovarian Cancer, University Hospital Cologne; Faculty of Medicine, University of Cologne and Institute for Health Economics and Clinical Epidemiology, Cologne; Institute for Public Health and Healthcare Research, University of Bremen; Institute for Human Genetics, University Hospital Heidelberg; Department of Obstetrics and Gynecology, Rechts der Isar Hospital Technical University of Munich; Schumpeter School of Business and Economics, Competence Center for Health Economics and Healthcare Research, University of Wuppertal; Department of Obstetrics and Gynecology, Carl Gustav Carus University Hospital, Dresden; Faculty of Medicine, University of Cologne and Center for Familial Breast and Ovarian Cancer, University Hospital Cologne; Institute for Health and Healthcare Science, Martin Luther University of Halle-Wittenberg, Halle (Saale); Department of Obstetrics and Gynecology, University Hospital Schleswig-Holstein, Kiel; Faculty of Medicine, University of Cologne and Department of Psychosomatics and Psychotherapy, University Hospital Cologne; Department of Psychosomatic Medicine, Robert Bosch Hospital, Stuttgart; Department of Obstetrics and Gynecology, University Hospital Würzburg.
Background: Women with pathogenic variants (PV) of the genes BRCA1/2 have a choice of preventive options. To help these women decide for themselves, we developed and implemented a decision coaching (DC) program and evaluated it for congruence between the participants' desired and actual roles in decision-making.
Methods: Healthy BRCA1/2 PV carriers (25-60 years of age) were recruited at six centers in Germany.
Postoperative Complications in Breast Reconstruction With Porcine Acellular Dermis and Polypropylene Meshes in Subpectoral Implant Placement.
In Vivo
August 2021
Interdisciplinary Breast Center, Clinic and Polyclinic for Gynecology and Obstetrics, University Medicine Greifswald, Greifswald, Germany.
Aim: This research compares postoperative complication rates with Strattice™, SERAGYN BR, and TiLOOP Bra interposition devices for subpectoral implant placement after skin or nipple sparing mastectomy.
Patients And Methods: 188 breast reconstructions in 157 patients after primary (n=96), secondary (n=71), or prophylactic (n=21) surgery were analyzed regarding major and minor complications.
Results: With acellular dermal matrix (ADM) Strattice™, 27.
Patient Quality of Life After Subpectoral Implant-based Breast Reconstruction With Synthetic or Biological Materials.
Anticancer Res
June 2021
Interdisciplinary Breast Center, Clinic and Polyclinic for Gynecology and Obstetrics, University Medicine Greifswald, Greifswald, Germany;
Aim: Quality of life and patient satisfaction after subpectoral breast reconstruction with meshes or acellular dermal matrices (ADM) and implants were assessed using the BreastQ questionnaire to investigate a potential influence of the materials on these parameters.
Patients And Methods: The BreastQ questionnaire was completed by 121 patients, who had received material-assisted, heterologous, subpectoral breast reconstruction between 2010 and 2018.
Results: Answers were similar independent of the reconstruction materials used.
Retrospective Study of Radiotherapy Impact on the Outcome of Material-assisted Implant-based Subpectoral Breast Reconstruction.
Anticancer Res
April 2021
Breast Center, Rechts der Isar Hospital Technical University of Munich, Munich, Germany.
Background/aim: Synthetic meshes (SMs) and acellular dermal matrices (ADMs) are used in reconstructive breast surgery. In the absence of prospective comparative studies, the identification of differences relies on retrospective analyses.
Patients And Methods: Our analysis focused on the impact of pre- and postoperative radiotherapy (RTX) and material-related differences.